CELLCYTE GENETICS CORP·4

Jan 20, 5:02 PM ET

LIEBER RANDY 4

4 · CELLCYTE GENETICS CORP · Filed Jan 20, 2010

Insider Transaction Report

Form 4
Period: 2010-01-07
LIEBER RANDY
DirectorPrincipal Accounting Officer
Transactions
  • Award

    Common Stock

    2010-01-07$0.03/sh+500,000$15,5001,664,150 total
  • Award

    Option

    2010-01-13$0.04/sh+4,200,000$147,0008,200,000 total
    Exercise: $0.04From: 2010-01-13Exp: 2015-01-13Common (4,200,000 underlying)
Footnotes (1)
  • [F1]Options shall vest and underlying shares shall become exercisable linearly per month, beginning on the first day of each month. On the first day of each month, so long as Mr. Lieber is a director of the Company, 350,000 options shall become exercisable.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT